1887
Volume 2012, Issue 2
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive inherited heart disease characterized by ventricular arrhythmias and sudden cardiac death especially in the young. ARVC has been traditionally associated with the Mediterranean basin, as many seminal studies on the disease have originated from research groups of this region. Today, however, numerous ARVC registries from all over the world emphasize that the disease does not have a specific racial or geographical predilection. This work provides a review on the global perspective of ARVC.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2012.26
2014-01-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2012/2/gcsp.2012.26.html?itemId=/content/journals/10.5339/gcsp.2012.26&mimeType=html&fmt=ahah

References

  1. Basso C Corrado D Marcus F Nava A Thiene C  Arrhythmogenic right ventricular cardiomyopathy, Lancet 2009; 373::12891300.
    [Google Scholar]
  2. Basso C Pilichou K Carturan E Rizzo S Bauce B Thiene G. Pathobiology of Arrhythmogenic Cardiomyopathy, Cardiac Electrophysiology Clinics 2011; 3::193204.
    [Google Scholar]
  3. Corrado D Basso C Pilichou K Thiene G. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart 2011; 97::530539.
    [Google Scholar]
  4. Thiene G Corrado D Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia, Orphanet journal of rare diseases 2007; 2::45.
    [Google Scholar]
  5. Basso C Corrado D Thiene G. Cardiovascular causes of sudden death in young individuals including athletes, Cardiology in review 1999; 7::127135.
    [Google Scholar]
  6. Corrado D Basso C Rizzoli G Schiavon M Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? Journal of the American College of Cardiology 2003; 42::195963.
    [Google Scholar]
  7. Lancisi, G. De motu cordis et anuerysmatibus. 1738.
  8. Marcus F Fontaine G Guiraudon G Frank R Laurenceau J Malergue C Grosgogeat Y. Right ventricular dysplasia: a report of 24 adult cases, Circulation 1982; 65::38498.
    [Google Scholar]
  9. Protonotarios N Tsatsopoulou A Patsourakos P Alexopoulos D Gezerlis P Simitsis S Scampardonis G. Cardiac abnormalities in familial palmoplantar keratosis, British heart journal 1986; 56::321326.
    [Google Scholar]
  10. Nava A Thiene G Canciani B Scognamiglio R Daliento L Buja G Martini B Stritoni P Fasoli G. Familial occurrence of right ventricular dysplasia: a study involving nine families, Journal of the American College of Cardiology 1988; 12::12221228.
    [Google Scholar]
  11. Thiene G Nava A Corrado D Rossi L. Cardiomyopathy and sudden death in young people, New England Journal of Medicine 1988; 318::129133.
    [Google Scholar]
  12. Rampazzo A Nava A Danieli GA Buja G Daliento L Fasoli G Scognamiglio R Corrado D Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24, Human molecular genetics 1994; 3::959962.
    [Google Scholar]
  13. McKoy G Protonotarios N Crosby A Tsatsopoulou A Anastasakis A Coonar A Norman M Baboonian C Jeffery S McKenna WJ. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease), Lancet 2000; 355::21192124.
    [Google Scholar]
  14. Norgett E Hatsell SJ Carvajal-Huerta L Cabezas JC Common J Purkis PE Whittock N Leigh M Stevens HP Kelsell DP. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma, Human molecular genetics 2000; 9::27612766.
    [Google Scholar]
  15. Rampazzo A Nava A Malacrida S Beffagna G Bauce B Rossi V Zimbello R Simionati B Basso C Thiene G Towbin JA Danieli GA. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy, American journal of human genetics 2002; 71::12001206.
    [Google Scholar]
  16. Bauce B Basso C Rampazzo A Beffagna G Daliento L Frigo G Malacrida S Settimo L Danieli G Thiene G Nava A. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations, European heart journal 2005; 26::16661675.
    [Google Scholar]
  17. Asimaki A Syrris P Wichter T Matthias P Saffitz J McKenna W. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy, American journal of human genetics 2007; 81::964973.
    [Google Scholar]
  18. Gerull B Heuser A Wichter T Paul M Basson CT McDermott DA Lerman BB Markowitz SM Ellinor PT MacRae CA Peters S Grossmann KS Drenckhahn J Michely B Sasse-Klaassen S Birchmeier W Dietz R Breithardt G Schulze-Bahr E Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy, Nature genetics 2004; 36::11621164.
    [Google Scholar]
  19. Pilichou K Nava A Basso C Beffagna G Bauce B Lorenzon A Frigo G Vettori A Valente M Towbin J Thiene G Danieli GA Rampazzo A. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy, Circulation 2006; 113::11711179.
    [Google Scholar]
  20. Syrris P Ward D Evans A Asimaki A Gandjbakhch E Sen-Chowdhry S McKenna WJ. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2, American journal of human genetics 2006; 79::978984.
    [Google Scholar]
  21. Klauke B Kossmann S Gaertner A Brand K Stork I Brodehl A Dieding M Walhorn V Anselmetti D Gerdes D Bohms B Schulz U Zu Knyphausen E Vorgerd M Gummert J Milting H. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy, Human molecular genetics 2010; 19::45954607.
    [Google Scholar]
  22. Xu T Yang Z Vatta M Rampazzo A Beffagna G Pilichou K Scherer SE Saffitz J Kravitz J Zareba W Danieli GA Lorenzon A Nava A Bauce B Thiene G Basso C Calkins H Gear K Marcus F Towbin JA. Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy, Journal of the American College of Cardiology 2010; 55::587597.
    [Google Scholar]
  23. Bauce B Nava A Beffagna G Basso C Lorenzon A Smaniotto G De Bortoli M Rigato I Mazzotti E Steriotis A Marra MP Towbin JA Thiene G Danieli GA Rampazzo A. Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart rhythm 2010; 7::2229.
    [Google Scholar]
  24. Hulot J Jouven X Empana J Frank R Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circulation 2004; 110::18791884.
    [Google Scholar]
  25. Wichter T Borggrefe M Haverkamp W Chen X Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia, Circulation 1992; 86::2937.
    [Google Scholar]
  26. Wichter T Paul TM Eckardt L Gerdes P Kirchhof P Böcker D Breithardt G. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz 2005; 30::91101.
    [Google Scholar]
  27. Wichter T Paul M Wollmann C Acil T Gerdes P Ashraf O Tjan TD Soeparwata R Block M Borggrefe M Scheld HH Breithardt G Böcker D. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients, Circulation 2004; 109::15031508.
    [Google Scholar]
  28. Corrado D Basso C Pavei A Michieli P Schiavon M Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program, Journal of the American Medical Association 2006; 296::15931601.
    [Google Scholar]
  29. Corrado D Leoni L Link MS Della Bella P Gaita F Curnis A Salerno JU Igidbashian D Raviele A Disertori M Zanotto G Verlato R Vergara G Delise P Turrini P Basso C Naccarella F Maddalena F Estes NA 3rd, Buja G Thiene G. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation 2003; 108::30843091.
    [Google Scholar]
  30. Suárez-Mier P Aguilera B. Causes of sudden death during sports activities in Spain, Revista española de cardiología 2002; 55::347358.
    [Google Scholar]
  31. de Noronha S Sharma S Papadakis M Desai S Whyte G Sheppard M. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study, Heart 2009; 95::14091414.
    [Google Scholar]
  32. Narin N  et al., Arrhythmogenic right ventricular cardiomyopathy (Naxos disease): report of a Turkish boy, Pacing and clinical electrophysiology 2003; 26::23262329.
    [Google Scholar]
  33. Djabali K Martinez-Mir A Horev L Klapholz L Glaser B Christiano A. Evidence for extensive locus heterozeneity in Naxos disease, J Invest Dermatol 2002; 118::557560.
    [Google Scholar]
  34. Watkins DA Hendricks N Shaboodien G Mbele M Parker M Vezi BZ Latib A Chin A Little F Badri M Moolman-Smook JC Okreglicki A Mayosi BM. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa, Heart Rhythm 2009; 6::S10S17.
    [Google Scholar]
  35. van Tintelen JP Entius MM Bhuiyan ZA Jongbloed R Wiesfeld AC Wilde AA van der Smagt J Boven LG Mannens MM van Langen IM Hofstra RM Otterspoor LC Doevendans PA Rodriguez LM van Gelder IC Hauer RN. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circulation 2006; 113::16501658.
    [Google Scholar]
  36. Komura M Suzuki J Adachi S Takahashi A Otomo K Nitta J Nishizaki M Obayashi T Nogami A Satoh Y Okishige K Hachiya H Hirao K Isobe M. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation, International heart journal 2010; 51::3440.
    [Google Scholar]
  37. Ma KJ Li N Wang HT Chu JM Fang PH Yao Y Ma J Hua W Zhang S Wang FZ Li Z Pu JL. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, Chinese Medical Journal 2009; 22::11331138.
    [Google Scholar]
  38. Dalal D Nasir K Bomma C Prakasa K Tandri H Piccini J Roguin A Tichnell C James C Russell SD Judge DP Abraham T Spevak PJ Bluemke DA Calkins H. Arrhythmogenic right ventricular dysplasia: a United States experience, Circulation 2005; 112::38233832.
    [Google Scholar]
  39. Carvajal-Huerta L. Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy, Journal of the American Academy of Dermatology 1998; 39::418420.
    [Google Scholar]
  40. Prompona M Kozlik-Feldmann R Mueller-Hoecker J Reiser M Huber A. Images in cardiovascular medicine. Magnetic resonance imaging characteristics in Carvajal syndrome (variant of Naxos disease), Circulation 2007; 116::e524530.
    [Google Scholar]
  41. Protonotarios N Tsatsopoulou A. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy, Cardiovascular pathology 2004; 13::185194.
    [Google Scholar]
  42. Simpson M Cook R Solanki P Patton M Dennis J Crosby A. A mutation in NFkappaB interacting protein 1 causes cardiomyopathy and woolly haircoat syndrome of Poll Hereford cattle, Animal genetics 2009; 40::4246.
    [Google Scholar]
  43. McKenna WJ Thiene G Nava A Fontaliran F Blomstrom-Lundqvist C Fontaine G Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society, Heart 1994; 71::215218.
    [Google Scholar]
  44. Corrado D Fontaine G Marcus FI McKenna WJ Nava A Thiene G Wichter T. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Need for an International Registry, Circulation 2000; 101::e101e106.
    [Google Scholar]
  45. Basso C Wichter T Danieli GA Corrado D Czarnowska E Fontaine G McKenna WJ Nava A Protonotarios N Antoniades L Wlodarska K D'Alessi F Thiene G. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking, European heart journal 2004; 25::531534.
    [Google Scholar]
  46. Marcus F Towbin JA Zareba W Moss A Calkins H Brown M Gear K  ARVD/C Investigators . Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol, Circulation 2003; 107::29752978.
    [Google Scholar]
  47. Marcus F McKenna W Sherrill D Basso C Bauce B Bluemke D Calkins H Corrado D Cox M Daubert J Fontaine G Gear K Hauer R Nava A Picard M Protonotarios N Saffitz J Sanborn D Steinberg J Tandri H Thiene G Towbin J Tsatsopoulou A Wichter T Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria, European heart journal 2010; 31::806814.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2012.26
Loading
/content/journals/10.5339/gcsp.2012.26
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error